Logo image of ZEN.BR

ZENOBE GRAMME (ZEN.BR) Stock Fundamental Analysis

Europe - EBR:ZEN - BE0003809267 - Common Stock

220 EUR
0 (0%)
Last: 9/26/2025, 7:00:00 PM
Fundamental Rating

2

Overall ZEN gets a fundamental rating of 2 out of 10. We evaluated ZEN against 74 industry peers in the Real Estate Management & Development industry. ZEN has a bad profitability rating. Also its financial health evaluation is rather negative. ZEN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ZEN had negative earnings in the past year.
ZEN had negative earnings in 4 of the past 5 years.
In the past 5 years ZEN always reported negative operating cash flow.
ZEN.BR Yearly Net Income VS EBIT VS OCF VS FCFZEN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2021 2023 2024 0 200K 400K 600K 800K 1M

1.2 Ratios

ZEN has a Return On Assets (-0.11%) which is in line with its industry peers.
ZEN's Return On Equity of -12.00% is on the low side compared to the rest of the industry. ZEN is outperformed by 68.00% of its industry peers.
ZEN's Return On Invested Capital of 12.15% is amongst the best of the industry. ZEN outperforms 97.33% of its industry peers.
Industry RankSector Rank
ROA -0.11%
ROE -12%
ROIC 12.15%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZEN.BR Yearly ROA, ROE, ROICZEN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2021 2023 2024 0 5 -5 10

1.3 Margins

The Operating Margin of ZEN (47.78%) is better than 74.67% of its industry peers.
ZEN's Operating Margin has declined in the last couple of years.
ZEN does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 47.78%
PM (TTM) N/A
GM N/A
OM growth 3Y-3.97%
OM growth 5Y-3.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZEN.BR Yearly Profit, Operating, Gross MarginsZEN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2021 2023 2024 0 10 20 30 40 50

More info and screens

2

2. Health

2.1 Basic Checks

ZEN has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ZEN has been reduced compared to 5 years ago.
ZEN has a better debt/assets ratio than last year.
ZEN.BR Yearly Shares OutstandingZEN.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2021 2023 2024 20 40 60 80
ZEN.BR Yearly Total Debt VS Total AssetsZEN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2021 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

ZEN has an Altman-Z score of 1.21. This is a bad value and indicates that ZEN is not financially healthy and even has some risk of bankruptcy.
ZEN has a Altman-Z score of 1.21. This is in the better half of the industry: ZEN outperforms 62.67% of its industry peers.
A Debt/Equity ratio of 78.50 is on the high side and indicates that ZEN has dependencies on debt financing.
With a Debt to Equity ratio value of 78.50, ZEN is not doing good in the industry: 89.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 78.5
Debt/FCF N/A
Altman-Z 1.21
ROIC/WACCN/A
WACCN/A
ZEN.BR Yearly LT Debt VS Equity VS FCFZEN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2021 2023 2024 2M 4M 6M

2.3 Liquidity

A Current Ratio of 0.27 indicates that ZEN may have some problems paying its short term obligations.
With a Current ratio value of 0.27, ZEN is not doing good in the industry: 85.33% of the companies in the same industry are doing better.
A Quick Ratio of 0.27 indicates that ZEN may have some problems paying its short term obligations.
ZEN's Quick ratio of 0.27 is on the low side compared to the rest of the industry. ZEN is outperformed by 77.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.27
Quick Ratio 0.27
ZEN.BR Yearly Current Assets VS Current LiabilitesZEN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2021 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

1

3. Growth

3.1 Past

Looking at the last year, ZEN shows a small growth in Revenue. The Revenue has grown by 0.43% in the last year.
Measured over the past years, ZEN shows a small growth in Revenue. The Revenue has been growing by 2.07% on average per year.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.91%
Revenue 1Y (TTM)0.43%
Revenue growth 3Y3.39%
Revenue growth 5Y2.07%
Sales Q2Q%1.67%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZEN.BR Yearly Revenue VS EstimatesZEN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2021 2023 2024 500K 1M 1.5M 2M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZEN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZEN.BR Price Earnings VS Forward Price EarningsZEN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZEN.BR Per share dataZEN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40 -60 -80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.80%, ZEN is a good candidate for dividend investing.
ZEN's Dividend Yield is rather good when compared to the industry average which is at 7.92. ZEN pays more dividend than 82.67% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, ZEN pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.8%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
ZEN.BR Yearly Income VS Free CF VS DividendZEN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2021 2023 2024 0 2K -2K 4K -4K

More info and screens

ZENOBE GRAMME

EBR:ZEN (9/26/2025, 7:00:00 PM)

220

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.20M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.8%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.13
P/FCF N/A
P/OCF N/A
P/B 188.57
P/tB 188.57
EV/EBITDA N/A
EPS(TTM)-95.41
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS35.88
BVpS1.17
TBVpS1.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.11%
ROE -12%
ROCE 16.2%
ROIC 12.15%
ROICexc 12.15%
ROICexgc 12.15%
OM 47.78%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-5.25%
ROICexcg growth 5Y1.71%
ROICexc growth 3Y-5.25%
ROICexc growth 5Y1.71%
OM growth 3Y-3.97%
OM growth 5Y-3.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 78.5
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.27
Quick Ratio 0.27
Altman-Z 1.21
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.91%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.43%
Revenue growth 3Y3.39%
Revenue growth 5Y2.07%
Sales Q2Q%1.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-7.96%
EBIT growth 3Y-0.71%
EBIT growth 5Y-1.79%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A